substance p has been researched along with Anticipatory Vomiting in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horiba, K; Ishikawa, N; Kanazawa, Y; Koizumi, M; Kudoh, H; Ohkawa, K; Seya, T; Shirakawa, T; Tajiri, T; Tanaka, N; Yamada, T; Yokoi, K; Yoshioka, M | 1 |
Hartvig, P | 1 |
Chikumi, H; Hitsuda, Y; Kawasaki, Y; Kometani, Y; Matsumoto, S; Matsumoto, Y; Mikami, M; Nakamoto, M; Sasaki, T; Tokuyasu, H | 1 |
3 other study(ies) available for substance p and Anticipatory Vomiting
Article | Year |
---|---|
[Substance P and anticancer drug-induced emesis].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Digestive System Neoplasms; Female; Humans; Male; Middle Aged; Nausea; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting, Anticipatory | 2007 |
Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Humans; Hydroxyindoleacetic Acid; Nausea; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Time Factors; Vomiting; Vomiting, Anticipatory | 2007 |
[Relationship between cancer chemotherapeutic drug-induced delayed emesis and plasma levels of substance P in two patients with small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Small Cell; Cisplatin; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Male; Serotonin; Serotonin Antagonists; Substance P; Vomiting, Anticipatory | 1999 |